The FDA has asked a panel of outside experts to evaluate the risk of nephrogenic systemic fibrosis (NSF) with a new MRI contrasting agent proposed by Bayer AG.
Tag Archives: GE Healthcare
Trial has been schedule to begin early next year for a lawsuit involving allegations that a gadolinium-based MRI contrast agent led to the development of nephrogenic systemic fibrosis (NSF), a…
The FDA is banning the use of three major brands of MRI contrast agent on patients with kidney problems, and is forcing other manufacturers to change their labels to bring more…
A Class 1 medical device recall has been issued for GE Healthcare Aisys and Avance Anesthesia Systems, which can fail to provide ventilation for patients under the affects of anesthetics.
More Top Stories
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to warn doctors to conduct hearing tests, which could have helped a woman avoid permanent hearing damage.
The U.S. Navy has received more than 129,000 Camp Lejeune water contamination claims, according to court records.
A Bard PowerPort lawsuit accuses the manufacturers of concealing known defects and complications from patients and the medical community.